FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
+7.66%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$101M
AUM Growth
–
Cap. Flow
+$101M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
51.34%
Holding
88
New
73
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$12.7M |
| 2 |
CELG
Celgene Corp
CELG
|
$6.57M |
| 3 |
Chipotle Mexican Grill
CMG
|
$6.44M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$6.35M |
| 5 |
Abbott
ABT
|
$5.49M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 58.06% |
| 2 | Consumer Discretionary | 8.21% |
| 3 | Materials | 5.13% |
| 4 | Consumer Staples | 4.96% |
| 5 | Technology | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $12.7M | 9.35% |
+125,233
| New | +$12.7M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $6.57M | 4.84% |
+54,834
| New | +$6.57M |
|
|
3
Chipotle Mexican Grill
CMG
$56.5B
| $6.44M | 4.75% |
+13,413
| New | +$6.44M |
|
|
DYAX
4
DELISTED
DYAX CORPORATION
DYAX
| $6.35M | 4.68% |
+168,700
| New | +$6.35M |
|
|
5
Abbott
ABT
$231B
| $5.49M | 4.05% |
+122,300
| New | +$5.49M |
|
6
Regeneron Pharmaceuticals
REGN
$61.5B
| $4.01M | 2.96% |
+7,390
| New | +$4.01M |
|
7
Humana
HUM
$36.5B
| $2.85M | 2.1% |
+15,935
| New | +$2.85M |
|
8
DuPont de Nemours
DD
$32.2B
| $2.64M | 1.95% |
+51,300
| New | +$2.64M |
|
9
Viatris
VTRS
$12.3B
| $2.57M | 1.89% |
+47,500
| New | +$2.57M |
|
10
United Therapeutics
UTHR
$13.8B
| $2.08M | 1.53% |
+13,267
| New | +$2.08M |
|
11
Mondelez International
MDLZ
$79.5B
| $1.97M | 1.45% |
+43,897
| New | +$1.97M |
|
|
LNKD
12
DELISTED
LinkedIn Corporation
LNKD
| $1.93M | 1.42% |
+8,577
| New | +$1.93M |
|
13
Heron Therapeutics
HRTX
$207M
| $1.9M | 1.4% |
+71,049
| New | +$1.9M |
|
14
IBM
IBM
$227B
| $1.88M | 1.38% |
+13,633
| New | +$1.88M |
|
|
RLYP
15
DELISTED
RELYPSA INC COM
RLYP
| $1.86M | 1.37% |
+65,537
| New | +$1.86M |
|
16
GameStop
GME
$10B
| $1.83M | 1.35% |
+65,174
| New | +$1.83M |
|
|
AGN
17
DELISTED
Allergan plc
AGN
| $1.77M | 1.31% |
+5,669
| New | +$1.77M |
|
|
POT
18
DELISTED
Potash Corp Of Saskatchewan
POT
| $1.71M | 1.26% |
+100,000
| New | +$1.71M |
|
|
LUMO
19
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.71M | 1.26% |
+46,913
| New | +$1.71M |
|
20
Biogen
BIIB
$19.4B
| $1.6M | 1.18% |
+5,216
| New | +$1.6M |
|
|
CEMP
21
DELISTED
Cempra, Inc.
CEMP
| $1.55M | 1.14% |
+49,672
| New | +$1.55M |
|
22
GE Aerospace
GE
$292B
| $1.53M | 1.13% |
+49,065
| New | +$1.53M |
|
23
Amgen
AMGN
$155B
| $1.53M | 1.13% |
+9,400
| New | +$1.53M |
|
|
CMRX
24
DELISTED
Chimerix, Inc.
CMRX
| $1.38M | 1.02% |
+154,100
| New | +$1.38M |
|
25
Cal-Maine
CALM
$5.61B
| $1.35M | 0.99% |
+29,054
| New | +$1.35M |
|